CINECA IRIS Institutional Research Information System

DE ANDREA, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.397
EU - Europa 6.010
AS - Asia 2.866
AF - Africa 193
SA - Sud America 125
OC - Oceania 78
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.226
IT - Italia 1.804
CN - Cina 1.480
IE - Irlanda 743
SE - Svezia 677
DE - Germania 523
FR - Francia 423
GB - Regno Unito 368
SG - Singapore 352
FI - Finlandia 320
UA - Ucraina 280
KR - Corea 267
AT - Austria 257
VN - Vietnam 176
PL - Polonia 173
JP - Giappone 166
IN - India 133
SN - Senegal 129
CA - Canada 124
NL - Olanda 93
DK - Danimarca 92
HK - Hong Kong 82
AU - Australia 72
BE - Belgio 65
BR - Brasile 54
TW - Taiwan 46
MX - Messico 41
ES - Italia 39
TR - Turchia 35
GR - Grecia 29
IR - Iran 27
PE - Perù 23
RU - Federazione Russa 23
RO - Romania 22
IL - Israele 20
ZA - Sudafrica 20
PK - Pakistan 15
SA - Arabia Saudita 15
CH - Svizzera 14
UG - Uganda 14
CZ - Repubblica Ceca 13
EC - Ecuador 13
NO - Norvegia 13
HR - Croazia 11
PH - Filippine 11
AR - Argentina 9
CL - Cile 9
IQ - Iraq 8
CO - Colombia 7
EG - Egitto 7
MY - Malesia 7
NZ - Nuova Zelanda 6
PT - Portogallo 6
BO - Bolivia 5
EE - Estonia 5
ID - Indonesia 5
PR - Porto Rico 4
QA - Qatar 4
RS - Serbia 4
SC - Seychelles 4
TH - Thailandia 4
EU - Europa 3
JO - Giordania 3
MA - Marocco 3
MU - Mauritius 3
NG - Nigeria 3
PY - Paraguay 3
TN - Tunisia 3
BD - Bangladesh 2
BG - Bulgaria 2
GH - Ghana 2
HU - Ungheria 2
KE - Kenya 2
LU - Lussemburgo 2
SI - Slovenia 2
ZM - Zambia 2
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
IS - Islanda 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
ME - Montenegro 1
NI - Nicaragua 1
NP - Nepal 1
SM - San Marino 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
YE - Yemen 1
Totale 18.672
Salva come PNG Salva come JPEG
Città #
Chandler 1.532
Houston 748
Dublin 732
Beijing 625
Fairfield 571
Ann Arbor 427
Torino 384
Ashburn 323
Woodbridge 319
Villeurbanne 257
Jacksonville 242
Vienna 241
Wilmington 240
Singapore 232
Seattle 223
Pisa 204
Cambridge 192
Princeton 189
Medford 188
Dearborn 175
Nyköping 175
Redwood City 152
Warsaw 152
Dong Ket 135
Turin 119
Sovicille 115
Guangzhou 97
Boston 94
Fremont 90
Shanghai 90
New York 89
Milan 82
Nanjing 63
Rome 63
Boardman 62
Piemonte 48
Toronto 46
Los Angeles 44
Hangzhou 38
Baltimore 37
San Diego 37
Tokyo 36
Brussels 34
Helsinki 34
Taipei 34
Seongnam 32
Washington 32
Phoenix 30
Norwalk 29
Novara 28
Chicago 27
London 27
Verona 26
Higashiayase 25
Lappeenranta 25
Silver Spring 25
Hefei 24
Kunming 24
New Delhi 24
Maddaloni 23
Philadelphia 23
Seoul 23
Santa Clara 22
Shenyang 22
Hebei 21
Paris 21
Pittsburgh 21
Wuhan 21
Jinan 20
Munich 19
Ottawa 18
Galveston 17
Melbourne 17
San Mauro Torinese 17
Utrecht 17
Orange 16
Chengdu 15
Elk Grove Village 15
Falls Church 15
Frankfurt am Main 15
Gongju 15
Ningbo 15
Zhengzhou 15
Berlin 14
Central 14
Des Moines 14
Madison 14
San Mateo 14
Buffalo 13
Chongqing 13
Changsha 12
Erlangen 12
Florence 12
Hamburg 12
Hanover 12
Hong Kong 12
Kampala 12
Padova 12
Vercelli 12
Bethesda 11
Totale 11.046
Salva come PNG Salva come JPEG
Nome #
Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy 425
The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion 352
Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease 336
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 315
Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders 305
Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells 285
α- and β-Papillomavirus infection in a young patient with an unclassified primary T-cell immunodeficiency and multiple mucosal and cutaneous lesions 276
Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children. [*Dell'Oste V, *Landolfo S, co-corresponding authors] 268
Identification of the skin virome in a young boy with widespread HPV2-positive warts that completely regressed after administration of tetravalent human papillomavirus vaccine. 255
Mislocalization of the interferon inducible protein IFI16 by environmental insults: Implications in autoimmunity 247
Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. 245
The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation 245
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 234
Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing. 234
Melusin is a new muscle-specific interactor for beta(1) integrin cytoplasmic domain. 229
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. 229
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 215
Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. M. DE ANDREA CO-FIRST AUTHOR 208
Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients 206
Analysis of human β-papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of patients with chronic lymphocytic leukaemia 188
In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16. M. DE ANDREA CO-FIRST AUTHOR 179
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 177
Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index 175
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 172
The interferon-inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory response 172
The US16 gene of human cytomegalovirus is equired for efficient viral infection of endothelial and epithelial cells.[Bronzini M.*, Luganini A.* co-first author] 170
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 166
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability [*Biolatti M, *Dell'Oste V, co-first authors] 165
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16 163
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters. M. DE ANDREA CO-FIRST AUTHOR 160
The intracellular DNA Sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication [*Gariano GR, *Dell'Oste V*, co-first authors] 157
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 156
Genotypic analysis of HCMV polymorphism in congenital infections to predict the impact of HCMV disease severity in newborns/infants 155
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 153
HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-β and IFN-λ1 Production through Transcriptional Repression of Multiple Downstream Effectors of Pattern Recognition Receptor Signaling. 151
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 144
Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer 143
Restriction factors against human CMV 141
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane Binding 138
The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: The dark side of sensing microbes 136
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 129
Evasion strategy of Human Cytomegalovirus from the antiviral activities of APOBEC3G 129
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters 127
Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape 126
Strigolactone analogs are promising antiviral agents against Herpesviruses 126
Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis 125
HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion 123
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 119
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 119
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 119
Lack of EVER2 Protein in Two Epidermodysplasia Verruciformis Patients with Skin Cancer Presenting Previously Unreported Homozygous Genetic Deletions in the EVER2 Gene 118
La proteina interferon-inducibile ifi16: fattore di restrizione per la replicazione degli herpesvirus umani 116
The interferon-inducibel IFI16 gene is a restriction factor for Human cytomegalovirus replication 115
Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability 114
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus 113
Interferon α/β 113
IFI16 expression is related to selected transcription factors during B-cell differentiation 111
The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation. 109
Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice 107
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity 106
THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD) 105
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 102
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 102
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 101
Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression 98
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis 98
A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation 98
β-HPV infection correlates with early stages of carcinogenesis in skin tumors and patient-derived xenografts from a kidney transplant recipient cohort 96
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 95
The antiproliferative activity of the murine interferon-inducible Ifi 200 proteins depends on the presence of two 200 amino acid domains. 95
HPV E7 Oncoprotein Subverts Host Innate Immunity Via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes 95
COMPARATIVE ANALYSIS OF HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATES FROM KIDNEY TRANSPLANT RECIPIENTS 93
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 91
The Intracellular DNA Sensor IFI16 Gene Acts as Restriction Factor for Human Cytomegalovirus Replication 88
The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication 88
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 87
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 87
Evasion Strategy of Human Cytomegalovirus to Escape Interferon-β-Induced APOBEC3G Editing Activity 86
A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity 86
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 85
High beta-HPV DNA Loads and Strong Seroreactivity Are Present in Epidermodysplasia Verruciformis 85
Bifunctional role of interferon inducible IFI16 protein inside and outside of endothelial cells 85
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity 85
Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis 84
HCMV TEGUMENT PROTEINS: NEW INSIGHTS ON INTERACTION BETWEEN THE DNA SENSOR PROTEIN IFI16 AND VIRION PARTICLES 84
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 84
The Mouse Interferon-Inducible Gene Ifi204 Product Interacts with the Tpr Protein, a Component of the Nuclear Pore Complex 83
The interferon-inducible 204 gene is transcriptionally activated by mouse cytomegalovirus and is required for its replication. M. DE ANDREA CO-FIRST AUTHOR 83
Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models 83
Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. 82
Tuning the Orchestra: HCMV vs. Innate Immunity. 82
Effects of IFI16 overexpression on the growth and doxorubicin sensitivity of head and neck squamous cell carcinoma-derived cell lines 82
The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. [*Azzimonti B, *Dell'Oste V, co-first authors] 81
Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cells 78
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 78
The anticytomegaloviral activity of raltitrexed is abrogated in quiescent mouse fibroblasts that overexpress thymidylate synthase 77
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 76
The interferon-inducible gene, Ifi204, acquires malignant transformation capability upon mutation at the Rb-binding sites. 75
The interferon-inducible gene IFI16, a member of the HIN200 family, triggers primary endothelial cell apoptosis through caspase 2 and caspase 3 pathway 74
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability 74
Totale 14.325
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.622
article - articoli 0
book - libri 0
conference - conferenze 19.469
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.091
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.835 0 111 161 316 225 713 316 189 257 218 160 169
2020/20212.307 195 125 142 186 230 160 217 139 229 222 147 315
2021/20222.320 103 128 143 234 104 92 129 136 87 168 569 427
2022/20234.268 262 207 87 455 477 1.005 235 353 678 123 202 184
2023/20242.100 264 296 145 132 174 258 100 130 30 156 163 252
2024/2025359 146 213 0 0 0 0 0 0 0 0 0 0
Totale 19.293